LLY - Eli Lilly and Company - Stock & Dividends

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a wide range of human pharmaceuticals. The company has a strong presence in the diabetes market, offering a variety of products, including Basaglar, Humalog, and Humulin, which are designed to help manage blood sugar levels. Additionally, Eli Lilly and Company offers several products for type 2 diabetes, including Jardiance, Mounjaro, and Trulicity. The company also provides products for obesity, such as Zepbound, which is designed to help individuals achieve and maintain weight loss.

In addition to its diabetes and obesity products, Eli Lilly and Company has a significant presence in the oncology market, offering a range of products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. These products are designed to help treat various types of cancer, including lung cancer, breast cancer, and lymphoma. The company also offers Olumiant, a product that is used to treat rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19. Furthermore, Eli Lilly and Company provides products for the treatment of plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis, including Taltz.

Eli Lilly and Company also offers a range of products for the treatment of various other conditions, including depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. The company's product portfolio includes Cymbalta, Ebglyss, and Emgality, which are designed to help manage these conditions. Additionally, Eli Lilly and Company offers products for the treatment of erectile dysfunction and benign prostatic hyperplasia, including Cialis, and osteoporosis, including Forteo.

The company has a strong commitment to innovation and has established collaborations with several other pharmaceutical companies, including Incyte Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd and Genentech, Inc., Biologics, Inc., AbCellera Biologics Inc., and Chugai Pharmaceutical Co., Ltd. These collaborations are designed to help drive innovation and advance the development of new products.

Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. The company has a long history of innovation and has established itself as a leader in the pharmaceutical industry. For more information, visit the company's website at https://www.lilly.com.